Free tool
FAERS Monitor: Pristiq
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021992 or its brand name (Pristiq, Desvenlafaxine Succinate). Reports on generic versions are filed under their own applications.
Reports
23,629
Serious
9,187
39% of reports
Hospitalization
2,603
Death reported
458
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,459
- nausea2,241
- headache1,794
- dizziness1,765
- anxiety1,654
- fatigue1,517
- insomnia1,466
- feeling abnormal1,383
- depression1,238
- drug withdrawal syndrome1,012
- malaise972
- diarrhoea862
- condition aggravated858
- off label use847
- pain798
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 1,213 |
| 2009 | 495 |
| 2010 | 4,881 |
| 2011 | 2,010 |
| 2012 | 2,244 |
| 2013 | 1,800 |
| 2014 | 717 |
| 2015 | 143 |
| 2016 | 1,718 |
| 2017 | 1,313 |
| 2018 | 903 |
| 2019 | 1,054 |
| 2020 | 918 |
| 2021 | 434 |
| 2022 | 1,034 |
| 2023 | 825 |
| 2024 | 701 |
| 2025 | 757 |
| 2026 | 469 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,530 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug withdrawal syndromeSignal | 1,012 | 10.4 | 9.8 | 8,500 |
| anxietySignal | 1,654 | 5.2 | 5.0 | 5,647 |
| feeling abnormalSignal | 1,383 | 5.2 | 4.9 | 4,662 |
| insomniaSignal | 1,466 | 4.9 | 4.7 | 4,609 |
| depressionSignal | 1,238 | 4.9 | 4.6 | 3,817 |
| dizzinessSignal | 1,765 | 3.2 | 3.0 | 2,654 |
| headacheSignal | 1,794 | 2.6 | 2.4 | 1,738 |
| nauseaSignal | 2,241 | 2.5 | 2.4 | 2,137 |
| condition aggravatedSignal | 858 | 2.5 | 2.4 | 792 |
| malaise | 972 | 2.0 | 1.9 | 476 |
| fatigue | 1,517 | 1.7 | 1.7 | 490 |
| drug ineffective | 2,459 | 1.7 | 1.6 | 690 |
| diarrhoea | 862 | 1.2 | 1.1 | 26 |
| pain | 798 | 1.2 | 1.1 | 17 |
| off label use | 847 | 0.9 | 0.8 | 20 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.